SCHEMBL30923208

SCHEMBL30923208

CCOC(=O)c1cnc(Cl)nc1Nc1cccc(-c2ccccn2)c1OC

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ SYK P43405 4/20 0.47
▸ ALOX15 P16050 3/20 0.47
▸ TSHR P16473 3/20 0.47
▸ NPSR1 Q6W5P4 3/20 0.47
▸ USP2 O75604 1/20 0.47
▸ TP53 P04637 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ IGF1R P08069 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27295983 1.00 MAPT (0.48) MAPTSMN1; SMN2ALDH1A1SYKALOX15
SCHEMBL27292564 0.90 MAPT (0.48) MAPTSMN1; SMN2ALDH1A1SYKALOX15
SCHEMBL30923379 0.86 PTK2 (0.49) MAPTSMN1; SMN2ALDH1A1ALOX15TSHR
SCHEMBL27296020 0.86 PTK2 (0.49) MAPTSMN1; SMN2ALDH1A1ALOX15TSHR
SCHEMBL27292717 0.83 MAPT (0.46) MAPTSMN1; SMN2ALDH1A1SYKALOX15
SCHEMBL30923185 0.83 MAPT (0.46) MAPTSMN1; SMN2ALDH1A1SYKALOX15
SCHEMBL31711666 0.82 TYK2 (0.49) MAPTSMN1; SMN2ALDH1A1SYKALOX15
SCHEMBL27293253 0.82 TYK2 (0.49) MAPTSMN1; SMN2ALDH1A1SYKALOX15
SCHEMBL27417045 0.82 JAK3 (0.52) MAPTSMN1; SMN2SYKALOX15TSHR
SCHEMBL30923257 0.81 SMN1; SMN2 (0.48) MAPTSMN1; SMN2ALDH1A1SYKALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4637738-A2 INHIBITORS OF JAK2 Llydaw Therapeutics, Inc. (US) 2025-10-29 — — EP disclosed
EP-4618975-A2 INHIBITORS OF TYK2 Vyrnwy Therapeutics, Inc. (US) 2025-09-24 — — EP disclosed
WO-2024107658-A2 INHIBITORS OF TYK2 VYRNWY THERAPEUTICS, INC. (US) 2024-05-23 — — WO disclosed
Send feedback